Clal Biotechnology reported 0 in Dividend Yield for its fiscal quarter ending in August of 2022.





Dy Change Date
Arca Biopharma 0 0 Mar/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cara Therapeutics 0 0 Mar/2025
Clal Biotechnology 0 0 Aug/2022
Compugen USD 0 0 May/2024
Infinity Pharmaceuticals 0 0 Jun/2023
Minerva Neurosciences 0 0 Mar/2025
TherapeuticsMD 0 0 Mar/2025